首页|类泛素化激活酶抑制剂PEV通过细胞衰老提高结肠癌细胞对5-氟尿嘧啶的敏感性

类泛素化激活酶抑制剂PEV通过细胞衰老提高结肠癌细胞对5-氟尿嘧啶的敏感性

扫码查看
细胞衰老与肿瘤细胞增殖减缓密切相关,细胞衰老抑制了许多癌基因的激活,因此诱导细胞衰老是现阶段一种干扰肿瘤细胞增殖过程的潜在策略,或许可以成为治疗肿瘤的有效途径.PEV(Pevonedistat)又称MLN4924,是NEDD8激活酶(NAE)抑制剂,可以通过阻断Cullin类泛素化使Cullin-RING E3泛素连接酶(CRL)失活.PEV可以抑制肿瘤细胞增殖,促进细胞凋亡、细胞衰老.5-氟尿嘧啶(5-FU)是结肠癌治疗中的一线化疗药物.PEV是否可以通过促进细胞衰老增强化疗药物5-FU的敏感性,提高结肠癌的治疗效果尚未可知.该研究对结肠癌细胞HCT116、HT29分别进行PEV单药处理、5-FU单药处理以及PEV与5-FU联合处理,通过β-半乳糖苷酶染色、Western blot、细胞3天连续计数、CCK-8实验、裸鼠皮下成瘤实验、免疫组化等实验对结肠癌细胞的衰老与增殖情况进行探究.结果提示,与溶媒组相比,PEV处理组与PEV、5-FU联合处理组半乳糖苷酶活性增加,P21、P27、PAI-1、P62等衰老相关蛋白表达水平增加以及细胞核形态标志物LaminB1缺失.同时与PEV单药处理组相比,PEV、5-FU联合处理组细胞衰老程度增加,对细胞增殖的抑制效果更为显著.该研究揭示类泛素化激活酶抑制剂PEV促进细胞衰老提高结肠癌对5-FU的敏感性,从而加剧细胞衰老、抑制细胞增殖.
Neddylation Activating Enzyme Inhibitor PEV Enhances the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil through Cell Senescence
Cell senescence is closely related to the slowing down of tumor cell proliferation,and cell se-nescence inhibits the activation of many oncogenes.Therefore,inducing cell senescence is a potential strategy to interfere with the important process of tumor cells proliferation at this stage,and may be an effective way to treat tumors.PEV(Pevonedistat),also known as MLN4924,is a NAE(NEDD8-activating enzyme)inhibitor that can inactivate CRL by blocking Cullin neddylation.PEV can inhibit the proliferation of tumor cells,promote cell apoptosis and senescence.5-FU(5-fluorouracil)is a first-line chemotherapy agent in the treatment of colorectal cancer.However,it is not known whether PEV can enhance the sensitivity of chemotherapy drug 5-FU and im-prove the therapeutic effect of colorectal cancer by promoting cell senescence.In this study,colorectal cancer cells HCT116 and HT29 were treated with PEV alone,5-FU alone and PEV combined with 5-FU respectively.Throughβ-galactosidase staining,Western blot,cell count for three days,CCK-8 test,mice and xenograft models,immuno-histochemistry and other experiments,it was proved that PEV promoted cell senescence,the combination of PEV and 5-FU accelerated cell senescence and increased the sensitivity of colorectal cancer to 5-FU.The inhibitory ef-fect on cell proliferation was more significant.The results showed that compared with the solvent group,the galac-tosidase activity,the expression of senescence-related proteins such as P21,P27,PAI-1,P62 and the loss of nuclear morphological marker LaminB1 were increased in PEV plus PEV and 5-FU groups.At the same time,compared with PEV single drug treatment group,PEV and 5-FU combined treatment group increased cell senescence and in-hibited cell proliferation more significantly.This study revealed that NEDD8-activating enzyme inhibitor PEV pro-motes cell senescence and increases the sensitivity of colorectal cancer to 5-FU,which aggravates cell senescence and inhibits cell proliferation.

neddylationcellular senescencecolorectal cancerchemotherapy drug sensitivity

花雨昕、倪梦珍、孙晴晴、翟潇晴、潘巍巍

展开 >

浙江中医药大学,基础医学院,杭州 310000

嘉兴大学医学院,细胞生物学教研室,嘉兴 314001

类泛素化 细胞衰老 结肠癌 化疗药物敏感性

国家自然科学基金浙江省自然科学基金浙江省自然科学基金浙江省自然科学基金"创新嘉兴·优才支持计划"先锋型创新团队项目

31871402LY21H160047LGD21H160003LQ23C070001

2024

中国细胞生物学学报
中国科学院上海生命科学研究院,生物化学与细胞生物学研究所,中国细胞生物学学会

中国细胞生物学学报

CSTPCD
影响因子:0.554
ISSN:1674-7666
年,卷(期):2024.46(6)
  • 44